Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway

Carcinogenesis

Volumn 29, Issue 6, 2008, Pages 1276-1281

  Ke, Qingdong ^a   Li, Qin ^a   Ellen, Thomas P ^a   Sun, Hong ^a   Costa, Max ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICKEL; PHOSPHATASE; SERINE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; EPIGENETICS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HISTONES; HUMANS; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASES; NICKEL; PHOSPHORYLATION; RNA, SMALL INTERFERING; SERINE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 46949090178     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn084     Document Type: Article

References (41)

1. van Holde,K.E. et al. (1989) Chromatin. Springer, Berlin.
2. Turner,B.M. (2007) Defining and epigenetic code. Nat. Cell Biol., 9, 2-6.
3. Zhang,Y. et al. (2001) Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev., 15, 2343-2360.
4. Hendzel,M.J. et al. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma, 106, 348-360.
5. Chadee,D.N. et al. (1999) Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem., 274, 24914-24920.
6. 2-terminal domain during mitotic chromosome condensation. J. Cell Biol., 145, 225-235.
7. Bradbury,E.M. (1992) Reversible histone modifications and the chromosome cell cycle. Bioessays., 14, 9-16.
8. Clayton,A. et al. (2000) Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19, 3714-3726.
9. Clayton,A.L. et al. (2003) MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett., 546 51-58.
10. Barratt,M.J. et al. (1994) Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc. Natl Acad. Sci. USA, 91, 4781-4785.
11. Thomson,S. et al. (1999) MAP kinase-mediated signaling to nucleosomes and immediate-early gene induction. Semin. Cell Dev. Biol., 10, 205-214.
12. Thomson,S. et al. (1999) The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 is a potential histone H3/HMG-14 kinase. EMBO J., 18, 4779-4793.
13. Cheung,P. et al. (2000) Signaling to chromatin through histone modifications. Cell, 103, 263-271.
14. Rea,S. et al. (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature, 406, 593-599.
15. Berger,S.L. (2002) Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev., 12, 142-148.
16. Fischle,W. et al. (2005) Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature, 438, 1116-1122.
17. Hirota,T. et al. (2005) Histone H3 serine 10 phosphorylation by Aurora B causes Hp1 dissociation from heterochromatin. Nature, 438, 1176-1180.
18. Oller,A.R. et al. (1997) Carcinogenicity assessment of selected nickel compounds. Toxicol. Appl. Pharmacol., 143, 152-166.
19. Sunderman,F.W.Jr., (1984) Carcinogenicity of Nickel Compounds in Animals. International Agency for Research on Cancer. IARC Scientific Publications, Lyon.
20. Trott,D.A. et al. (1995) Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis, 16, 193-204.
21. Biggart,N.W. et al. (1986) Assessment of the uptake and mutagenicity of nickel chloride in salmonella tester strains. Mutat. Res., 175, 209-215.
22. Biedermann,K.A. et al. (1987) Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res., 47, 3815-3823.
23. Klein,C. et al. (1994) Metal mutagenesis in transgenic Chinese hamster cell lines. Environ. Health Perspect., 102 (suppl. 3), 63-67.
24. Lee,Y.-W. et al. (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: A new model for epigenetic carcinogens. Mol. Cell. Biol., 15, 2547-2557.
25. Ke,Q. et al. (2006) Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis, 27, 1481-1488.
26. Chen,H. et al. (2006) Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol. Cell. Biol., 26, 3728-3737.
27. Kang,J. et al. (2003) Nickel-induced histone hypoacetylation: The role of reactive oxygen species. Toxicol. Sci., 74, 279-286.
28. Govindarajan,B. et al. (2002) Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol. Med., 8, 1-8.
29. 2 and 2,4-dinitrochlorobenzene. J. Invest. Dermatol., 120, 390-399.
30. Boisleve,F. et al. (2004) Nickel and DNCB induce CCR7 expression on human dendritic cells through different signaling pathways: Role of TNF-α and MAPK. J. Invest. Dermatol., 123, 494-502.
31. Huang,X. et al. (1993) Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence. Toxicol. Appl. Pharmacol., 120, 29-36.
32. Huang,C. et al. (2001) Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide. Cancer Res., 61, 8051-8057.
33. ICNCM. (1990). Report of the International Committee on Nickel Carcinogenesis in Man. Scand. J. Work Environ. Health, 16, 1-82.
34. Davidson,T. et al. (2003) Hypoxia inducible factor-1α-independent suppression of aryl hydrocarbon receptor-regulated genes by nickel. Mol. Pharmacol., 64, 1485-1493.
35. Sutherland,J.E. et al. (2001) The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. Mutat. Res., 479, 224-233.
36. He,Z. et al. (2003) Arsenite-induced phosphorylation of histone H3 at serine 10 is mediated by Atk1, extracellular signal-regulated kinase 2, and p90 ribosomal S6 kinase 2 but not mitogen- and stress-activated protein kinase 1. J. Biol. Chem., 278, 10588-10593.
37. Zhong,S. et al. (2000) ERKs and p38 kinases mediate ultraviolet B-induced phosphorylation of histone H3 at serine 10. J. Biol. Chem. 275, 20980-20984.
38. Pitot,H.C. et al. (1998) Chemical Carcinogenesis. McGraw-Hill, New York, NY Chapter 8.
39. Ke,Q. et al. (2008) Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity. Toxicol. Appl. Pharmacol. in press.
40. Ke,Q. (2006) Alteration of histone modifications by nickel compounds - a possible epigenetic mechanism of nickel carcinogenesis. Dissertation New York University School of Medicine, Department of Environmental Medicine, New York, NY.
41. Jenuwein,T. et al. (2001) Translating the histone code. Science 293, 1074-1080.